SCHEMBL6843417

SCHEMBL6843417

[3H][CH]CON1C(=O)c2ccccc2C1=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.58
GAA P10253 1/20 0.56
KMT2A Q03164 3/20 0.49
CYP1A2 P05177 3/20 0.49
MAPT P10636 3/20 0.49
MEN1 O00255 2/20 0.49
CYP2C9 P11712 1/20 0.49
HTT P42858 1/20 0.45
RECQL P46063 1/20 0.44
ATM Q13315 1/20 0.43
KDM4E B2RXH2 2/20 0.41
HPGD P15428 2/20 0.41
POLB P06746 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
TDP1 Q9NUW8 1/20 0.39
CYP3A4 P08684 1/20 0.38
XBP1 P17861 1/20 0.38
CYP2C19 P33261 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
VDR P11473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3289291 0.86 ALDH1A1 (0.63) ALDH1A1GAAKMT2ACYP1A2MAPT
SCHEMBL13545621 0.79 GAA (0.69) ALDH1A1GAAKMT2ACYP1A2MAPT
SCHEMBL22326350 0.77 GAA (0.88) ALDH1A1GAAKMT2ACYP1A2MAPT
SCHEMBL17650674 0.75 GAA (0.64) ALDH1A1GAAKMT2ACYP1A2MAPT
SCHEMBL13108193 0.74 GAA (0.62) ALDH1A1GAAKMT2ACYP1A2MAPT
SCHEMBL2081294 0.74 GAA (0.62) ALDH1A1GAAKMT2ACYP1A2MAPT
SCHEMBL6570943 0.74 GAA (0.74) ALDH1A1GAAKMT2ACYP1A2MAPT
SCHEMBL7475276 0.74 GAA (0.62) ALDH1A1GAAKMT2ACYP1A2MAPT
SCHEMBL1715729 0.73 ALDH1A1 (1.00) ALDH1A1GAAKMT2ACYP1A2MAPT
SCHEMBL30767916 0.73 ALDH1A1 (1.00) ALDH1A1GAAKMT2ACYP1A2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6762169-B1 IMPROVED TRANSMEMBRANE DELIVERY OF NUCLEOSIDES CONJUGATED TO AN ARYLPROPIONIC ACID LIGAND (IBUPROFEN) WHICH HAS AFFINITY FOR PLASMA PROTEIN ALBUMIN; ANTISENSE THERAPY ISIS PHARMACEUTICALS, INC. 2004-07-13 US disclosed
EP-1185305-A1 LIGAND-CONJUGATED OLIGOMERIC COMPOUNDS ISIS PHARMACEUTICALS, INC. (US) 2002-03-13 EP disclosed
WO-2000076554-A1 LIGAND-CONJUGATED OLIGOMERIC COMPOUNDS ISIS PHARMACEUTICALS, INC. (US) 2000-12-21 WO disclosed